S
Schuster Medical Research Institute | Sherman Oaks, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
KarXT
Bapineuzumab
Cariprazine
Atogepant
Lasmiditan
BMS-820836
SEP-363856
MK-8189
Aripiprazole
Leuco-methylthioninium Bis(Hydromethanesulfonate)
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 34 total trials
This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic o...
Active, not recruiting
Chronic Migraine
Episodic Migraine
Drug: Atogepant 60 mg
Trial sponsors
T
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems